U.S. Markets open in 1 hr 22 mins
  • S&P Futures

    3,603.50
    +27.50 (+0.77%)
     
  • Dow Futures

    29,859.00
    +313.00 (+1.06%)
     
  • Nasdaq Futures

    11,937.75
    +32.50 (+0.27%)
     
  • Russell 2000 Futures

    1,842.40
    +25.30 (+1.39%)
     
  • Crude Oil

    43.65
    +0.59 (+1.37%)
     
  • Gold

    1,809.00
    -28.80 (-1.57%)
     
  • Silver

    23.17
    -0.46 (-1.94%)
     
  • EUR/USD

    1.1869
    +0.0024 (+0.2018%)
     
  • 10-Yr Bond

    0.8570
    0.0000 (0.00%)
     
  • Vix

    22.00
    -1.70 (-7.17%)
     
  • GBP/USD

    1.3327
    +0.0005 (+0.0387%)
     
  • USD/JPY

    104.5490
    +0.0610 (+0.0584%)
     
  • BTC-USD

    19,180.37
    +728.40 (+3.95%)
     
  • CMC Crypto 200

    377.79
    +16.36 (+4.53%)
     
  • FTSE 100

    6,406.59
    +72.75 (+1.15%)
     
  • Nikkei 225

    26,165.59
    +638.22 (+2.50%)
     

Motus GI to Release Third Quarter 2020 Results and Provide a Business Update on November 12

Motus GI Holdings, Inc.
·1 min read

FORT LAUDERDALE, Fla., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that the Company will release its third quarter 2020 financial results on Thursday, November 12, 2020, after the market close. Management will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide updates on recent corporate developments.

Conference Call and Webcast

Date and Time:

Thursday, November 12th at 4:30 p.m. ET

Domestic:

877-407-0792

International:

201-689-8263

Passcode:

13711588

Webcast:

www.motusgi.com or http://public.viavid.com/index.php?id=141815

A replay of the webcast will be archived on the Motus GI website, www.motusgi.com, for 90 days following the event.

About Motus GI

Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions.

For more information, visit www.motusgi.com and connect with the Company on Twitter, LinkedIn and Facebook.

Investor Contact:
Bob Yedid
LifeSci Advisors
(646) 597-6989
bob@lifesciadvisors.com